Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study on the Correlation of Isotype Switching, Neutralizing Antibody Titer and Cross Immunity Against COVID-19 Variants After Primary and Booster Vaccination

NCT05087277 is registered in ClinicalTrials.gov with Centers for Disease Control and Prevention, China as lead sponsor.

NCT NCT05087277
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05087277 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study on the Correlation of Isotype Switching, Neutralizing Antibody Titer and Cross Immunity Against COVID-19 Variants After Primary and Booster Vaccination
Lead sponsor
Centers for Disease Control and Prevention, China
Phase
Observational
Overall status
Unknown status
Start date
July 20, 2020
Completion date
October 30, 2021
Enrollment
150 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19